MTTlab has entered into a commercial partnership with Remembrane.
MTTlab Srl, a CRO specializing in biomedical, biotechnological and pharmaceutical testing services, announced a new commercial partnership with Remembrane Srl, a biotech company focused on membrane lipidomics of in-vitro cultures and a manufacturer of the Refeed® cell culture supplements.
Under the terms of the agreement, MTTlab can use and commercialize the Refeed® technology to enhance the performance of in-vitro models.
MTTlab specializes in a variety of biomedical, biotechnological, pharmaceutical and food & beverage testing services, as well as providing assistance with early to mid-stage drug development.
MTTlab delivers both in vitro and in vivo data sets for the preclinical evaluation of an investigational compound which can be used for regulatory submissions, project evaluation, scientific publications and fund raising. MTTlab provides support for our clients’ studies or project from the earliest stages and assists with both scientific and regulatory challenges to obtain valid results within requested deadlines.
Remembrane developed a proprietary technology to cater for the production of tailor-made lipid supplements, which offer superior flexibility in terms of output quality and deployment in all cell culture settings and applications.
Thanks to the Remembrane technology and know-how, each tailor-made Refeed® formulation enhances key performance biological or commercial parameters such as protein production, virus production, cryopreservation, quality of physiological models and pathological models, lipid media formulations, stem cells & cell therapy, transfection, etc.